Form 4/A for BBIO BridgeBio Pharma, Inc.
Accepted 2025-06-30 00:00:00 ET · period of report 2021-12-29 · accession 0000950170-25-091759 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-06-30 | 2021-12-29 | BBIO | Valantine Hannah | Dir | P - Purchase | $14.24 | +1,752 | 3,294 | +114% | +$24.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-29 | P | A | 1,752 | $14.24 | 3,294 | D | — | — |